Keita Iguchi

Title: Keita Iguchi: Innovator in Protein Engineering

Introduction

Keita Iguchi is a prominent inventor based in Takasago, Japan. He has made significant contributions to the field of protein engineering, particularly in the development of novel ligands for immunoglobulin binding. With a total of 4 patents to his name, Iguchi's work is paving the way for advancements in affinity separation technologies.

Latest Patents

Iguchi's latest patents include a protein capable of binding specifically to immunoglobulin and an immunoglobulin-binding affinity ligand. The first patent focuses on creating a novel engineered Protein A ligand that exhibits improved antibody dissociation properties in acidic conditions compared to existing engineered Protein A ligands. This invention provides a protein with an affinity for immunoglobulin, featuring an amino acid sequence derived from various domains of Protein A, with specific substitutions that enhance its functionality.

The second patent addresses the development of engineered protein ligands that maximize binding capacity and efficiency for affinity separation matrices. This invention outlines methods for immobilizing protein ligands on carriers, resulting in antibody affinity separation matrices characterized by excellent binding properties.

Career Highlights

Iguchi is currently employed at Kaneka Corporation, where he continues to innovate in the field of protein engineering. His work has garnered attention for its potential applications in biotechnology and pharmaceuticals.

Collaborations

Iguchi collaborates with notable colleagues, including Shinichi Yoshida and Dai Murata, who contribute to his research and development efforts.

Conclusion

Keita Iguchi's contributions to protein engineering and his innovative patents are instrumental in advancing the field of immunoglobulin binding technologies. His work at Kaneka Corporation and collaborations with esteemed colleagues further enhance the impact of his inventions.